Wuling San ameliorates urate under-excretion and renal dysfunction in hyperuricemic mice

Chinese Journal of Natural Medicines

Volumn 11, Issue 3, 2013, Pages 214-221

  Ding, Xiao Qin ^a   Pan, Ying ^a   Wang, Xing ^a   Ma, Yu Xiang ^a   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

GLUT9; Hyperuricemia; OAT1; OCT1 2; OCTN2; URAT1; Wuling San

Indexed keywords

ALLOPURINOL; CARRIER PROTEIN; CHINESE DRUG; CREATININE; GLUCOSE TRANSPORTER 9; HERBACEOUS AGENT; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; UNCLASSIFIED DRUG; URATE; URATE TRANSPORTER 1; URIC ACID; WULING SAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DOWN REGULATION; EXCRETION; HYPERURICEMIA; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; WESTERN BLOTTING;

EID: 84878449067     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60019-9     Document Type: Article

References (31)

1. Tatsuno I, Saito Y Hyperuricemia in hypertension [J]. Nihon Rinsho 2001, 59(5):967-972.
2. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease [J]. J Am Soc Nephrol 2002, 13(12):2888-2897.
3. Dehghan A, van Hoek M, Sijbrands EJ, et al. High serum uric acid as a novel risk factor for type 2 diabetes [J]. Diabetes Care 2008, 31(2):361-362.
4. Kang DH, Nakagawa T Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease [J]. Semin Nephrol 2005, 25(1):43-49.
5. Choi HK, Mount DB, Reginato AM Pathogenesis of gout [J]. Ann Intern Med 2005, 143(7):499-516.
6. Enomoto A, Endou H Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease [J]. Clin Exp Nephrol 2005, 9(3):195-205.
7. Preitner F, Bonny O, Laverriere A, et al. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy [J]. Proc Natl Acad Sci USA 2009, 106(36):15501-15506.
8. Rule AD, de Andrade M, Matsumoto M, et al. Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families [J]. Rheumatology (Oxford) 2011, 50(5):871-878.
9. Imaoka T, Kusuhara H, Adachi-Akahane S, et al. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules [J]. J Am Soc Nephrol 2004, 15(8):2012-2022.
10. Wang CP, Wang X, Zhang X, et al. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice [J]. J Pharm Pharm Sci 2010, 13(3):411-427.
11. Spiekerkoetter U, Huener G, Baykal T, et al. Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2 [J]. J Inherit Metab Dis 2003, 26(6):613-615.
12. Tang ZL Yinchen Wuling San treated 98 cases of patients suffering from acute urathritis [J]. Clin J Anhui Tradit Chin Med 2002, 14(6):464.
13. BAO J Clinical effects of modified Wuling San on the treatment of 48 cases of patients suffering from urathritis [J]. Yunnan J Tradit Chin Mater Med 2004, 25(4):4.
14. Wang YM, Zhang YY Clinical reserch of modified Wuling San on hyperuricimia [J]. Beijing J Tradit Chin Med 2003, 22(1):19.
15. Guan SM Pingwei San and Wuling San treat 36 cases of patients suffering from hyperuricemia [J]. Modern Chin J Inter Med 2008, 17(5):690.
16. Han YP, Wang NS, Mi SQ, et al. Effect of Wuling Powder on adriamycin-induced nephrotic syndrome in rats [J]. Tradit Chin Drug Res Pharmacol 2003, 14(4):223-267.
17. Han YP, Wang NS, Mi SQ, et al. Effect of Wuling San on renal hypertension in rats [J]. J Chin Integr Med 2003, 1(4):285-288.
18. Huang H, Gao ZX, Wang HM, et al. Regulating effect of modified Yinchen Wuling Powder on xanthine oxidase activity in rats with hyperuricemia [J]. J Fujian Univer Tradit Chin Med 2010, 20(4):33-34.
19. Carroll JJ, Coburn H, Douglass R, et al. A simplified alkaline phosphotungstate assay for uric acid in serum [J]. Clin Chem 1971, 17(3):158-160.
20. Perez-Ruiz F, Calabozo M, Erauskin GG, et al. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output [J]. Arthritis Rheum 2002, 47(6):610-613.
21. Yuan D, Mori J, Komatsu KI, et al. An anti-aldosteronic diuretic component (drain dampness) in Polyporus sclerotium [J]. Biol Pharm Bull 2004, 27(6):867-870.
22. Cao ZG, Liu JH, Zhou SW, et al. The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model. [J]. Chin Med J 2004, 84(15):1276-1279.
23. Ma BD Report about using lots of Rhizomal Alismatis to treat 120 cases of patients suffering from acute urathritis [J]. Liaoning J Tradit Chin Med 2007, 34(4):480-481.
24. +)-adenosine triphosphatase] [J]. Yakugaku Zasshi 1991, 111(2):138-145.
25. Li JJ, Chen XM, Gu Y, et al. The renoprotect effect of shenhua recipe on 5/6 renal ablation rats [J]. China J Chin Mater Med 2005, 30(5):377-381.
26. Monden T, Hosoya T, Nakajima Y, et al. Herbal medicine, Hachimi-jio-gan, and its component cinnamomi cortex activate the peroxisome proliferator-activated receptor alpha in renal cells [J]. Endocr J 2008, 55(3):529-533.
27. Lin CC, Wu SJ, Chang CH, et al. Antioxidant activity of Cinnamomum cassia [J]. Phytother Res 2003, 17(7):726-730.
28. Nakagawa T, Goto H, Hikiami H, et al. Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats [J]. J Ethnopharmacol 2007, 110(2):311-317.
29. Wu SJ, Ng LT, Lin CC Antioxidant activities of some common ingredients of traditional chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos [J]. Phytother Res 2004, 18(12):1008-1012.
30. Hattori T, Hayashi K, Nagao T, et al. Studies on antinephritic effects of plant components (3): Effect of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms [J]. Jpn J Pharmacol 1992, 59(1):89-96.
31. Liu IM, Tzeng TF, Liou SS, et al. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription [J]. J Ethnopharmacol 2009, 124(2):211-218.